HER2

Low-cost lensfree holography and AI enable reliable automated HER2 scoring for breast cancer pathology - EurekAlert!

FDA approves drug for patients with HR+, HER2+ advanced breast cancer based on results from alliance foundation trials PATINA trial - EurekAlert!

Dana-Farber Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in advanced HER2-expressing malignancies - EurekAlert!

Adding tucatinib to first-line maintenance therapy delayed disease progression in HER2-positive metastatic breast cancer in HER2CLIMB-05 trial - EurekAlert!

HER2-targeted therapy shows promising results in rare bile duct cancers - EurekAlert!

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model - EurekAlert!

HER2-mutated NSCLC in Brazil shows diverse genetic patterns and treatment gaps - EurekAlert!

AACR: HER2 targeted therapy shows promise in previously treated lung cancers - EurekAlert!

HER2-low breast cancer: Genomic insights and evolving treatment paradigms - EurekAlert

Trastuzumab emtansine improves long-term survival in HER2 breast cancer - EurekAlert

Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancer - EurekAlert

Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer

Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer - EurekAlert

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial

PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy